Literature DB >> 27137523

Non-invasive Renal Denervation: Update on External Ultrasound Approaches.

Roland E Schmieder1, Christian Ott2, Peter Bramlage3.   

Abstract

In the last decade, intravenous renal denervation (RDN) has emerged as an alternative to pharmacological treatment in patients with resistant hypertension, but currently involves an invasive and technically challenging procedure. The Surround Sound™ system utilises externally delivered ultrasound to achieve RDN using a completely non-invasive, automated real-time tracking system coupled with a therapeutic delivery module thereby addressing these limitations. A brief history, technical overview and summary of preclinical and clinical studies of the KonaMedical Surround Sound™ system are presented. A literature search using the terms "renal denervation", "resistant hypertension" and "external ultrasound" was performed using PubMed, and references retrieved were selected based on relevancy and year of publication (date range 1991-2015). The Surround Sound™ system appears to be a promising approach to RDN which eliminates several of the factors currently limiting the intravenous approach. So far, it has demonstrated efficacy for reducing blood pressure in resistant hypertension patients with minimal adverse effects. Several double-blind, sham-controlled clinical trials are currently underway to confirm the validity of these findings.

Entities:  

Keywords:  Blood pressure; Doppler imaging; High-frequency focused ultrasound; Renal denervation; Resistant hypertension

Mesh:

Year:  2016        PMID: 27137523     DOI: 10.1007/s11906-016-0653-6

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  26 in total

1.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.

Authors:  Brent M Egan; Yumin Zhao; R Neal Axon
Journal:  JAMA       Date:  2010-05-26       Impact factor: 56.272

Review 2.  Functional role of renal afferents.

Authors:  A Stella; A Zanchetti
Journal:  Physiol Rev       Date:  1991-07       Impact factor: 37.312

3.  Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design.

Authors:  Felix Mahfoud; Michael Böhm; Michel Azizi; Atul Pathak; Isabelle Durand Zaleski; Sebastian Ewen; Kostantinos Tsioufis; Bert Andersson; Peter J Blankestijn; Michel Burnier; Gilles Chatellier; Sameer Gafoor; Guido Grassi; Michael Joner; Sverre E Kjeldsen; Thomas Felix Lüscher; Melvin D Lobo; Chaim Lotan; Gianfranco Parati; Josep Redon; Luis Ruilope; Isabella Sudano; Christian Ukena; Evert van Leeuwen; Massimo Volpe; Stephan Windecker; Adam Witkowski; William Wijns; Thomas Zeller; Roland E Schmieder
Journal:  Eur Heart J       Date:  2015-05-18       Impact factor: 29.983

Review 4.  Overview of therapeutic ultrasound applications and safety considerations.

Authors:  Douglas L Miller; Nadine B Smith; Michael R Bailey; Gregory J Czarnota; Kullervo Hynynen; Inder Raj S Makin
Journal:  J Ultrasound Med       Date:  2012-04       Impact factor: 2.153

5.  Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension.

Authors:  Steffen Desch; Thomas Okon; Diana Heinemann; Konrad Kulle; Karoline Röhnert; Melanie Sonnabend; Martin Petzold; Ulrike Müller; Gerhard Schuler; Ingo Eitel; Holger Thiele; Philipp Lurz
Journal:  Hypertension       Date:  2015-03-30       Impact factor: 10.190

6.  Noninvasive renal sympathetic denervation by extracorporeal high-intensity focused ultrasound in a pre-clinical canine model.

Authors:  Qifeng Wang; Rui Guo; Shunkang Rong; Gang Yang; Que Zhu; Yonghong Jiang; Changming Deng; Dichuan Liu; Qi Zhou; Qi Wu; Shunhe Wang; Jun Qian; Qi Wang; Han Lei; Tong-Chuan He; Zhibiao Wang; Jing Huang
Journal:  J Am Coll Cardiol       Date:  2013-03-26       Impact factor: 24.094

7.  Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008.

Authors:  Brent M Egan; Yumin Zhao; R Neal Axon; Walter A Brzezinski; Keith C Ferdinand
Journal:  Circulation       Date:  2011-08-08       Impact factor: 29.690

8.  Resistant hypertension: demography and clinical characteristics in 6,292 patients in a primary health care setting.

Authors:  Teresa Gijón-Conde; Auxiliadora Graciani; José R Banegas
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2014-02-05

9.  International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension.

Authors:  Markus P Schlaich; Roland E Schmieder; George Bakris; Peter J Blankestijn; Michael Böhm; Vito M Campese; Darrel P Francis; Guido Grassi; Dagmara Hering; Richard Katholi; Sverre Kjeldsen; Henry Krum; Felix Mahfoud; Giuseppe Mancia; Franz H Messerli; Krzysztof Narkiewicz; Gianfranco Parati; Krishna J Rocha-Singh; Luis M Ruilope; Lars C Rump; Domenic A Sica; Paul A Sobotka; Costas Tsioufis; Oliver Vonend; Michael A Weber; Bryan Williams; Thomas Zeller; Murray D Esler
Journal:  J Am Coll Cardiol       Date:  2013-09-18       Impact factor: 24.094

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  2 in total

1.  Clinical Potential of Nerve Input to Tumors: A Bioelectricity Perspective.

Authors:  Jade A Phillips; Charlotte Hutchings; Mustafa B A Djamgoz
Journal:  Bioelectricity       Date:  2021-03-16

Review 2.  Device-Based Therapy for Resistant Hypertension: An Up-to-Date Review.

Authors:  Oussama Jami; Youssef Tijani; Aziz Et-Tahir
Journal:  High Blood Press Cardiovasc Prev       Date:  2022-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.